Robert W. Cook's Net Worth
$31.3 Thousand
Who is Robert W. Cook?
Robert W. Cook does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include PHARMOS CORP, CorMedix Inc., MELA SCIENCES, INC. /NY, and IMMUNE PHARMACEUTICALS INC.
SEC CIK
Robert W. Cook's CIK is 0001235438
Past Insider Trading and Trends
2007 was Robert W. Cook's most active year for acquiring shares with 8 total transactions. Robert W. Cook's most active month to acquire stocks was the month of December. 2003 was Robert W. Cook's most active year for disposing of shares, totalling 5 transactions. Robert W. Cook's most active month to dispose stocks was the month of September. 2018 saw Robert W. Cook paying a total of $29,212.50 for 70,000 shares, this is the most they've acquired in one year. In 2003 Robert W. Cook cashed out on 80,000 shares for a total of $133,647.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PHARMOS CORP No price found
Executive Vice President & CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
|
—
|
0
|
$2.70 | -$57,800.00 | 19K |
Nov 10
| |||
Form 4
|
—
|
0
|
$1.90 | -$25,847.00 | 19K |
Oct 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CorMedix Inc. (CRMD) Snapshot price: $2.945
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +3.77% | 1K |
$6.88 | $6,879.30 | 27.52K |
Sep 30
| |||
Form 4
| +3.92% | 1K |
$8.18 | $8,180.00 | 26.52K |
Aug 16
| |||
Form 4
| +3.92% | 1K |
$8.18 | $8,180.00 | 26.52K |
Aug 16
| |||
Form 4
| +0.39% | 100 |
$9.35 | $935.00 | 25.52K |
Mar 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 10
| |||
Form 4
| +24.49% | 25K |
$1.17 | $29,212.50 | 127.08K |
Nov 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
| +104.17% | 52.08K |
$0.48 | $24,999.84 | 102.08K |
Dec 12
| |||
Form 4
|
∞
| 50K |
$0.50 | $24,950.00 | 50K |
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MELA SCIENCES, INC. /NY (SSKN) Snapshot price: $0.57
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
|
∞
| 10K |
$1.23 | $12,294.00 | 10K |
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IMMUNE PHARMACEUTICALS INC No price found
CFO and Senior VP
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
| +818.82% | 450K |
—
|
—
| 504.96K |
Dec 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
| +50.00% | 5K |
$1.35 | $6,750.00 | 15K |
Dec 13
| |||
Form 4
|
∞
| 10K |
$1.67 | $16,654.12 | 10K |
Aug 29 - Aug 30
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jan 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||